股本结构
单位：万股
| 公告日期 | 2025-11-06 | 2025-11-06 | 2025-08-07 | 2025-08-07 | 2025-05-22 | 2025-05-22 |
|---|---|---|---|---|---|---|
| 证券总股本 | 7844.33 | 7840.33 | 7805.58 | 7780.72 | 7708.68 | 7708.50 |
| 普通股本 | 7844.33 | 7840.33 | 7805.58 | 7780.72 | 7708.68 | 7708.50 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2025-11-03 | 2025-09-30 | 2025-08-04 | 2025-06-30 | 2025-05-19 | 2025-03-31 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2025-11-06 | 7844.33 | 未披露 | 定期报告 | 2025-11-03 |
| 2025-11-06 | 7840.33 | 未披露 |
更多>>
From June 30, 2025 to September 30, 2025
Exercise of pre-funded warrants
Vesting of RSUs
|
2025-09-30 |
| 2025-08-07 | 7805.58 | 未披露 | 定期报告 | 2025-08-04 |
| 2025-08-07 | 7780.72 | 未披露 |
更多>>
From March 31, 2025 to June 30, 2025
Exercise of stock options
Vesting of RSUs
|
2025-06-30 |
| 2025-05-22 | 7708.68 | 未披露 | 定期报告 | 2025-05-19 |
| 2025-05-22 | 7708.50 | 未披露 |
更多>>
From March 31, 2024 to March 31, 2025
Issuance of common stock, net of issuance costs and underwriter fees
Vesting of RSUs
Exercise of stock options
Exercise of pre-funded warrants
|
2025-03-31 |
| 2025-02-12 | 7701.48 | 未披露 | 定期报告 | 2025-02-07 |
| 2025-02-12 | 7700.91 | 未披露 |
更多>>
From September 30, 2024 to December 31, 2024
Issuance of common stock, net of issuance costs and underwriter fees
Exercise of stock options
Vesting of RSUs
|
2024-12-31 |
| 2024-11-26 | 7534.04 | 未披露 |
更多>>
Common stock offered 6,923,000 shares by the company
|
2024-11-27 |
| 2024-11-12 | 6841.74 | 未披露 | 定期报告 | 2024-11-08 |
| 2024-11-12 | 6839.46 | 未披露 |
更多>>
From June 30, 2024 to September 30, 2024
Exercise of stock options
Vesting of RSUs
|
2024-09-30 |
| 2024-07-19 | 6832.14 | 未披露 | 定期报告 | 2024-07-08 |
| 2024-08-08 | 6831.00 | 未披露 |
更多>>
From March 31, 2024 to June 30, 2024
Vesting of RSUs
Issuance of common stock in connection with private placement, net of placement agent fees and offering costs
Exercise of stock options
Exercise of pre-funded warrants
|
2024-06-30 |
| 2024-06-13 | 6708.40 | 未披露 |
更多>>
Replimune Group, Inc. Agreed to issue and sell to the Investors an aggregate of 5,668,937 shares of the Company's common stock.
|
2024-06-12 |
| 2024-05-16 | 6141.51 | 未披露 |
更多>>
From March 31, 2023 to March 31, 2024
Exercise of pre-funded warrants
Exercise of stock options
Vesting of RSUs
|
2024-03-31 |
| 2024-02-08 | 6138.78 | 未披露 |
更多>>
From September 30, 2023 to December 31, 2023
Exercise of stock options
Vesting of RSUs
|
2023-12-31 |
| 2023-11-07 | 5905.93 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Exercise of stock options
Vesting of RSUs
|
2023-09-30 |
| 2023-07-26 | 5899.63 | 未披露 | 定期报告 | 2023-07-17 |
| 2023-08-03 | 5806.97 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Exercise of stock options
Exercise of pre-funded warrants
Vesting of RSUs
|
2023-06-30 |
| 2023-05-18 | 5777.60 | 未披露 | 定期报告 | 2023-05-15 |
| 2023-05-18 | 5667.63 | 未披露 |
更多>>
From March 31, 2022 to March 31, 2023
Exercise of stock options
Issuance of common stock through ATM sales, net of offering costs
Issuance of common stock, net of issuance costs and underwriter fees
Vesting of RSUs
|
2023-03-31 |
| 2023-02-09 | 5665.50 | 未披露 | 定期报告 | 2023-02-06 |
| 2023-02-09 | 5663.30 | 未披露 |
更多>>
From September 30, 2022 to December 31, 2022
Issuance of common stock, net of issuance costs and underwriter fees
Exercise of stock options
Vesting of RSUs
|
2022-12-31 |
| 2022-12-12 | 5511.39 | 未披露 |
更多>>
Common stock offered 5,374,486 shares by the company
|
2022-12-13 |
| 2022-11-03 | 4973.94 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Issuance of common stock through ATM sales, net of offering costs
Exercise of stock options
Vesting of RSUs
|
2022-09-30 |
| 2022-08-04 | 4930.67 | 未披露 | 定期报告 | 2022-08-01 |
| 2022-07-27 | 4930.64 | 未披露 | 定期报告 | 2022-07-21 |
| 2022-08-04 | 4929.85 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Vesting of RSUs
Issuance of common stock through ATM sales, net of offering costs
Exercise of stock options
|
2022-06-30 |
| 2022-05-19 | 4907.00 | 未披露 | 定期报告 | 2022-05-16 |
| 2022-05-19 | 4733.87 | 未披露 |
更多>>
From March 31, 2021 to March 31, 2022
Exercise of stock options
Vesting of restricted stock units
|
2022-03-31 |
| 2022-02-03 | 4720.95 | 未披露 | 定期报告 | 2022-01-31 |
| 2022-02-03 | 4720.63 | 未披露 |
更多>>
From September 30, 2021 to December 31, 2021
Exercise of stock options
|
2021-12-31 |
| 2021-11-04 | 4689.35 | 未披露 | 定期报告 | 2021-11-02 |
| 2021-11-04 | 4685.53 | 未披露 | 定期报告 | 2021-09-30 |
| 2021-08-06 | 4677.23 | 未披露 | 定期报告 | 2021-08-02 |
| 2021-08-06 | 4673.05 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Exercise of stock options
|
2021-06-30 |
| 2021-05-20 | 4660.90 | 未披露 | 定期报告 | 2021-05-17 |
| 2021-05-20 | 4656.65 | 未披露 |
更多>>
From March 31, 2020 to March 31, 2021
Issuance of common stock, net of issuance costs and underwriter fees of $18,892
Exercise of stock options
|
2021-03-31 |
| 2021-02-04 | 4649.35 | 未披露 | 定期报告 | 2021-02-01 |
| 2021-02-04 | 4638.47 | 未披露 |
更多>>
From September 30, 2020 to December 31, 2020
Exercise of stock options
Issuance of common stock, net of issuance costs and underwriter fees of $13,775
|
2020-12-31 |
| 2020-11-05 | 4596.24 | 未披露 | 定期报告 | 2020-11-02 |
| 2020-10-26 | 4496.79 | 未披露 |
更多>>
1.Common stock the company is offering: 4,687,500 shares.
2.The number of shares of common stock to be outstanding after this offering, as set forth above, is based on 40,280,420 shares of common stock outstanding as of June 30, 2020.
|
2020-10-26 |
| 2020-11-05 | 4031.23 | 未披露 |
更多>>
From June 30, 2020 to September 30, 2020
Exercise of stock options
|
2020-09-30 |
| 2020-08-07 | 4028.83 | 未披露 | 定期报告 | 2020-08-04 |
| 2020-07-29 | 4045.81 | 未披露 | 定期报告 | 2020-07-28 |
| 2020-08-07 | 4028.04 | 未披露 |
更多>>
From March 31, 2020 to June 30, 2020
Issuance of common stock, net of issuance costs and underwriter fees of $5,117
Exercise of stock options
|
2020-06-30 |
| 2020-07-01 | 4014.70 | 未披露 |
更多>>
The Company issued and sold an additional 652,173 shares of its common stock to the underwriters for the offering at the public offering price of $23.00 per share, less underwriting discounts and commissions, representing the full exercise of the underwriters’ option to purchase additional shares of the Company’s common stock. As of June 29, 2020, the Company has issued and sold an aggregate of 3,478,261 shares of its common stock
|
2020-06-29 |
| 2020-06-11 | 3949.48 | 未披露 |
更多>>
1.Common stock offering 2,826,088 shares.
2.The number of shares of our common stock to be outstanding after this offering, is based on 36,668,743 shares of our common stock outstanding as of March 31, 2020.
|
2020-06-11 |
| 2020-06-03 | 3678.41 | 未披露 | 定期报告 | 2020-05-29 |
| 2020-06-03 | 3666.87 | 未披露 |
更多>>
from March 31, 2019 to March 31, 2020
Issuance of common stock through ATM sales, net of offering costs
Issuance of common shares upon closing of follow-on public offering, net of issuance costs and underwriter fees of $4,017
Exercise of stock options
|
2020-03-31 |
| 2020-02-13 | 3664.57 | 未披露 |
更多>>
from September 30, 2019 to December 31, 2019
Issuance of common stock through ATM sales, net of offering costs
Issuance of common shares upon closing of follow-on public offering, net of issuance costs and underwriter fees of $4,017
Exercise of stock options
|
2019-12-31 |
| 2019-11-18 | 3539.74 | 未披露 | 定期报告 | 2019-11-18 |
| 2019-11-12 | 3200.86 | 未披露 | 定期报告 | 2019-11-08 |
| 2019-11-12 | 3171.93 | 未披露 |
更多>>
from June 30, 2019 to September 30, 2019
Exercise of stock options
|
2019-09-30 |
| 2019-07-29 | 3166.62 | 未披露 | 定期报告 | 2019-07-17 |
| 2019-08-14 | 3166.37 | 未披露 |
更多>>
from March 31, 2019 to June 30, 2019
Exercise of stock options
|
2019-06-30 |
| 2019-06-28 | 3166.37 | 未披露 | 定期报告 | 2019-06-21 |
| 2019-06-28 | 3165.70 | 未披露 |
更多>>
from March 31, 2018 to March 31, 2019
Conversion of convertible preferred stock into common stock upon closing of initial public offering
Repurchase of class A common stock upon closing of initial public offering
Issuance of common stock upon closing of initial public offering, net of issuance costs and underwriter fees of $9,935
Exercise of stock options
|
2019-03-31 |
| 2019-02-14 | 3164.68 | 未披露 | 定期报告 | 2019-02-12 |
| 2019-02-14 | 3164.07 | 未披露 |
更多>>
From March 31, 2017 to December 31, 2018
Conversion of convertible preferred stock into common stock upon closing of initial public offering
Repurchase of class A common stock upon closing of initial public offering
Issuance of common stock upon closing of initial public offering, net of issuance costs and underwriter fees of $9,935
Exercise of stock options
|
2018-12-31 |
| 2018-11-14 | 3155.37 | 未披露 |
更多>>
From March 31, 2018 to September 30, 2018
Conversion of convertible preferred stock into common stock upon closing of initial public offering
Repurchase of class A common stock upon closing of initial public offering
Issuance of common stock upon closing of initial public offering, net of issuance costs and underwriter fees of $9,935
Exercise of stock options
|
2018-09-30 |
| 2018-08-30 | 3155.37 | 未披露 | 定期报告 | 2018-08-29 |
| 2018-07-23 | 3083.86 | 未披露 |
更多>>
1.Common stock offered 6,700,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 24,138,587 shares of our common stock outstanding as of March 31, 2018
3.A 1-for-9.94688 forward stock split of our common stock effected on July 9, 2018
|
2018-07-20 |
| 2018-08-30 | 503.37 | 192.60 | 定期报告 | 2018-06-30 |
| 2018-06-22 | 52.70 | 192.60 |
更多>>
From March 31, 2017 to March 31, 2018
Issuance of series B convertible preferred stock, net of $198 issuance costs
Issuance of common A stock
Stock options in exchange for consulting services
|
2018-03-31 |
From June 30, 2025 to September 30, 2025
Exercise of pre-funded warrants
Vesting of RSUs
From March 31, 2025 to June 30, 2025
Exercise of stock options
Vesting of RSUs
From March 31, 2024 to March 31, 2025
Issuance of common stock, net of issuance costs and underwriter fees
Vesting of RSUs
Exercise of stock options
Exercise of pre-funded warrants
From September 30, 2024 to December 31, 2024
Issuance of common stock, net of issuance costs and underwriter fees
Exercise of stock options
Vesting of RSUs
Common stock offered 6,923,000 shares by the company
From June 30, 2024 to September 30, 2024
Exercise of stock options
Vesting of RSUs
From March 31, 2024 to June 30, 2024
Vesting of RSUs
Issuance of common stock in connection with private placement, net of placement agent fees and offering costs
Exercise of stock options
Exercise of pre-funded warrants
Replimune Group, Inc. Agreed to issue and sell to the Investors an aggregate of 5,668,937 shares of the Company's common stock.
From March 31, 2023 to March 31, 2024
Exercise of pre-funded warrants
Exercise of stock options
Vesting of RSUs
From September 30, 2023 to December 31, 2023
Exercise of stock options
Vesting of RSUs
From June 30, 2023 to September 30, 2023
Exercise of stock options
Vesting of RSUs
From March 31, 2023 to June 30, 2023
Exercise of stock options
Exercise of pre-funded warrants
Vesting of RSUs
From March 31, 2022 to March 31, 2023
Exercise of stock options
Issuance of common stock through ATM sales, net of offering costs
Issuance of common stock, net of issuance costs and underwriter fees
Vesting of RSUs
From September 30, 2022 to December 31, 2022
Issuance of common stock, net of issuance costs and underwriter fees
Exercise of stock options
Vesting of RSUs
Common stock offered 5,374,486 shares by the company
From June 30, 2022 to September 30, 2022
Issuance of common stock through ATM sales, net of offering costs
Exercise of stock options
Vesting of RSUs
From March 31, 2022 to June 30, 2022
Vesting of RSUs
Issuance of common stock through ATM sales, net of offering costs
Exercise of stock options
From March 31, 2021 to March 31, 2022
Exercise of stock options
Vesting of restricted stock units
From September 30, 2021 to December 31, 2021
Exercise of stock options
From March 31, 2021 to June 30, 2021
Exercise of stock options
From March 31, 2020 to March 31, 2021
Issuance of common stock, net of issuance costs and underwriter fees of $18,892
Exercise of stock options
From September 30, 2020 to December 31, 2020
Exercise of stock options
Issuance of common stock, net of issuance costs and underwriter fees of $13,775
1.Common stock the company is offering: 4,687,500 shares.
2.The number of shares of common stock to be outstanding after this offering, as set forth above, is based on 40,280,420 shares of common stock outstanding as of June 30, 2020.
From June 30, 2020 to September 30, 2020
Exercise of stock options
From March 31, 2020 to June 30, 2020
Issuance of common stock, net of issuance costs and underwriter fees of $5,117
Exercise of stock options
The Company issued and sold an additional 652,173 shares of its common stock to the underwriters for the offering at the public offering price of $23.00 per share, less underwriting discounts and commissions, representing the full exercise of the underwriters’ option to purchase additional shares of the Company’s common stock. As of June 29, 2020, the Company has issued and sold an aggregate of 3,478,261 shares of its common stock
1.Common stock offering 2,826,088 shares.
2.The number of shares of our common stock to be outstanding after this offering, is based on 36,668,743 shares of our common stock outstanding as of March 31, 2020.
from March 31, 2019 to March 31, 2020
Issuance of common stock through ATM sales, net of offering costs
Issuance of common shares upon closing of follow-on public offering, net of issuance costs and underwriter fees of $4,017
Exercise of stock options
from September 30, 2019 to December 31, 2019
Issuance of common stock through ATM sales, net of offering costs
Issuance of common shares upon closing of follow-on public offering, net of issuance costs and underwriter fees of $4,017
Exercise of stock options
from June 30, 2019 to September 30, 2019
Exercise of stock options
from March 31, 2019 to June 30, 2019
Exercise of stock options
from March 31, 2018 to March 31, 2019
Conversion of convertible preferred stock into common stock upon closing of initial public offering
Repurchase of class A common stock upon closing of initial public offering
Issuance of common stock upon closing of initial public offering, net of issuance costs and underwriter fees of $9,935
Exercise of stock options
From March 31, 2017 to December 31, 2018
Conversion of convertible preferred stock into common stock upon closing of initial public offering
Repurchase of class A common stock upon closing of initial public offering
Issuance of common stock upon closing of initial public offering, net of issuance costs and underwriter fees of $9,935
Exercise of stock options
From March 31, 2018 to September 30, 2018
Conversion of convertible preferred stock into common stock upon closing of initial public offering
Repurchase of class A common stock upon closing of initial public offering
Issuance of common stock upon closing of initial public offering, net of issuance costs and underwriter fees of $9,935
Exercise of stock options
1.Common stock offered 6,700,000 shares
2.The number of shares of our common stock to be outstanding after this offering is based on 24,138,587 shares of our common stock outstanding as of March 31, 2018
3.A 1-for-9.94688 forward stock split of our common stock effected on July 9, 2018
From March 31, 2017 to March 31, 2018
Issuance of series B convertible preferred stock, net of $198 issuance costs
Issuance of common A stock
Stock options in exchange for consulting services